- Home
- NCI vs CSCI Comparison
NCI vs CSCI Comparison
Compare NCI & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCI
- CSCI
- Stock Information
- Founded
- NCI 1992
- CSCI 1990
- Country
- NCI Hong Kong
- CSCI Canada
- Employees
- NCI N/A
- CSCI N/A
- Industry
- NCI
- CSCI
- Sector
- NCI
- CSCI
- Exchange
- NCI NYSE
- CSCI NYSE
- Market Cap
- NCI 10.1M
- CSCI 11.1M
- IPO Year
- NCI 2024
- CSCI 1996
- Fundamental
- Price
- NCI $0.56
- CSCI $2.80
- Analyst Decision
- NCI
- CSCI
- Analyst Count
- NCI 0
- CSCI 0
- Target Price
- NCI N/A
- CSCI N/A
- AVG Volume (30 Days)
- NCI 352.1K
- CSCI 12.4K
- Earning Date
- NCI 12-19-2024
- CSCI 03-26-2025
- Dividend Yield
- NCI N/A
- CSCI N/A
- EPS Growth
- NCI N/A
- CSCI N/A
- EPS
- NCI 0.08
- CSCI N/A
- Revenue
- NCI $22,481,862.00
- CSCI $4,834,000.00
- Revenue This Year
- NCI N/A
- CSCI N/A
- Revenue Next Year
- NCI N/A
- CSCI N/A
- P/E Ratio
- NCI $7.39
- CSCI N/A
- Revenue Growth
- NCI N/A
- CSCI N/A
- 52 Week Low
- NCI $0.35
- CSCI $2.38
- 52 Week High
- NCI $11.39
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- NCI N/A
- CSCI N/A
- Support Level
- NCI N/A
- CSCI N/A
- Resistance Level
- NCI N/A
- CSCI N/A
- Average True Range (ATR)
- NCI 0.00
- CSCI 0.00
- MACD
- NCI 0.00
- CSCI 0.00
- Stochastic Oscillator
- NCI 0.00
- CSCI 0.00
About NCI NEO-CONCEPT INTL GRP HLDGS LTD
Neo-Concept International Group Holdings Ltd is a company whose a one-stop apparel solution services provider. It offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European, and North American markets through Neo-Concept HK.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.